UBS MSCI Switzerland 20/35 UCITS ETF hGBP dis

What this fund is

UBS MSCI Switzerland 20/35 UCITS ETF hGBP dis is an exchange-traded fund (ETF) from UBS, traded under the ticker UC94 (ISIN LU1169830442). One trade buys a whole basket of holdings, so your money is spread out instead of riding on a single company. In plain terms it is about owning small slices of companies, so you share in their growth when they do well — and their falls when they don't, focused on the European market. It follows the MSCI Switzerland 20/35 index (passive investing): it tracks the market rather than relying on a manager, keeping running costs down, and its largest holdings include ROCHE HLDG PC PRP, NOVARTIS AG-REG and NESTLE SA-REG. By geography it is weighted towards ~75.2% Switzerland.

Its heaviest sectors are ~30.6% Health Care and ~15.5% Financials. Funds like this are commonly chosen by investors who want a regular cash income stream rather than reinvesting everything for growth. Its ongoing charge (TER) is 0.23% a year — about €23 a year on a €10,000 holding, taken automatically from the fund. It is a distributing share class — dividends are paid to you as cash rather than reinvested, and over the last year it paid out roughly 0.03% (its trailing yield). It holds the underlying investments directly (physical replication); it is domiciled in Luxembourg and UCITS-regulated, a European standard built to protect everyday investors and trades in GBP.

Its price has swung about 12.7% over the past year — a gauge of how much the value moves, not a judgement of quality. It launched in 2015. Like any investment, it can lose value as well as gain, and what it did before does not predict what it will do next. (Fund data sourced from UBS.)